510(k) device
Cala Trio
Cala Health, Inc. · External Upper Limb Tremor Stimulator (QBC, Class II) · First FDA decision Oct 5, 2021, newest Oct 5, 2021Essential tremor
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Cala Trio"
MAUDE reports
0
Brand "Cala Trio", since 2015
PubMed studies
1
Mentioning "Cala Trio"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cala Trio
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- External Upper Limb Tremor Stimulator TherapyLocal determinationIn effectL39591CGS Administrators, LLCUpdated Feb 16, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Cala Trio", any status and sponsor, newest update first.
- RWE Study Utilizing the Cala Trio Device in Patients With Essential TremorPivotal-lookingCompleted
Cala Health, Inc.Not on our public-company list
NCT05540626 · 276 participants · Start Apr 8, 2021 · Primary completion Mar 1, 2024
Device: Cala Trio · For: Essential Tremor
Sites: San Mateo, California
Cala Health, Inc.Not on our public-company list
NCT05480215 · 20 participants · Start Oct 7, 2021 · Primary completion Dec 16, 2021
Device: Cala Device · For: Essential Tremor; Parkinson Disease
Sites: San Mateo, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cala Trio", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QBC
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cala Trio"[tiab]. The summary above synthesizes these.
- Shaking Up Essential Tremor: Peripheral Devices and Mechanical Strategies to Reduce Tremor.
Adabi K, Ondo WG · Tremor Other Hyperkinet Mov (N Y) · 2024Review
Other devices of this type
Also filed under product code QBC.
- Cala kIQCala Health, Inc. · 510(k) 2025
- Cala kIQ PlusCala Health, Inc. · 510(k) 2026
- Encora X1Encora, Inc. · 510(k) 2026
- Felix NeuroAI SystemFasikl Incorporated · 510(k) 2025
- External upper limb tremor stimulatorCala Health, Inc. · 510(k) 2018
- Cala ONECala Health, Inc. · De Novo 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.